New research shows combining Mediterranean polyphenols with ketogenic fats improves mitochondrial function in HD models, while time-restricted eating enhances therapeutic ketosis and autophagy. Phase ...
New clinical studies demonstrate time-restricted eating’s potential to slow Huntington’s progression through circadian optimization and enhanced autophagy, with major research institutions...
Recent studies suggest time-restricted eating may delay Huntington’s disease symptoms by enhancing mitochondrial function and autophagy, with human trials currently underway. Emerging research indic...
A new clinical trial explores time-restricted eating for Huntington’s disease, building on recent research showing benefits for mitochondrial function and autophagy. A groundbreaking clinical trial ...
A 12-week clinical trial explores time-restricted eating’s potential to improve mitochondrial function and autophagy in early-stage Huntington’s disease patients. Groundbreaking research i...
A 12-week clinical trial at the University of Florida investigates time-restricted eating in early-stage Huntington’s disease, with potential benefits for mitochondrial function and cognitive pe...
A 12-week TRE protocol (6h window) is being tested for early Huntington’s Disease, showing potential benefits for mitochondrial function and autophagy with 80% adherence expected. New clinical t...
Emerging research suggests time-restricted feeding may improve symptoms and slow neurodegeneration in Huntington’s disease through circadian rhythm synchronization and enhanced autophagy. New cl...
Recent research reveals how intermittent fasting protocols interact with circadian rhythms to improve insulin sensitivity, gut microbiome diversity, and metabolic markers beyond weight loss. Emerging ...
A 12-week clinical trial explores time-restricted eating’s potential to enhance mitochondrial function and reduce oxidative stress in early-stage Huntington’s disease. A new clinical trial inv...
